Navigating The New Landscape Of Cosmetic Regulation: How Maven Can Help With MOCRA Registration

The U.S. cosmetics industry is undergoing its most significant regulatory transformation in decades. With the enactment of the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), the U.S. Food and Drug Administration (FDA) now hold expanded authority to regulate cosmetic products, manufacturers, and safety oversight.

Implemented on December 29, 2022, MoCRA introduces mandatory facility registration, cosmetic product listing, adverse event reporting, safety substantiation, GMP compliance, and recall authority, fundamentally reshaping how cosmetic companies operate in the United States.

For brands, contract manufacturers, private label companies, and importers, compliance is no longer optional, it is a legal and strategic necessity. Maven Regulatory Solutions provides structured regulatory intelligence, compliance strategy, and technical documentation support to help cosmetic companies achieve full MOCRA compliance efficiently and confidently.

Understanding MOCRA: A Historic Regulatory Shift

MoCRA represents the most comprehensive amendment to the Federal Food, Drug, and Cosmetic Act since its enactment in 1938. Unlike prior cosmetic oversight, which relied heavily on voluntary reporting, MoCRA establishes enforceable federal requirements.

Why MOCRA Matters

• Expands FDA authority over cosmetic manufacturers
• Mandates facility registration and product listing
• Introducing serious adverse event reporting requirements
• Grants FDA mandatory recall authority
• Strengthens cosmetic safety substantiation standards
• Enhance regulatory enforcement mechanisms

This law applies to skincare products, fragrances, makeup, nail care, personal hygiene items, haircare products, and imported cosmetics marketed in the United States.

Key Definitions Under MOCRA

Understanding these definitions is critical for implementing compliant internal regulatory systems.

New FDA Authorities Under MOCRA

1. Records Access Authority

The FDA can now inspect and copy safety substantiation records when evaluating product risk.

2. Mandatory Recall Authority

If a cosmetic product poses a health risk, the FDA may mandate a recall when voluntary action is not initiated.

3. Suspension of Facility Registration

Facilities may face registration suspension if products present serious adverse health consequences.

Core MOCRA Compliance Requirements

1. Facility Registration

All cosmetic manufacturing and processing facilities must:

• Register with the FDA
• Renew registration every two years
• Provide accurate operational and contact details
• Update registration within 60 days of changes

Foreign facilities exporting cosmetics to the U.S. must also comply.

2. Cosmetic Product Listing

Each marketed cosmetic product must be listed with the FDA, including:

• Product name and category
• Responsible person details
• Complete ingredient disclosure
• Facility information

Annual updates are required to maintain compliance.

3. Adverse Event Reporting

Responsible people must:

• Report serious adverse events within 15 business days
• Submit a copy of the product label
• Maintain records of all adverse events for six years

This requirement strengthens post-market surveillance and consumer safety monitoring.

4. Safety Substantiation Requirements

Manufacturers must maintain “adequate substantiation of safety,” meaning:

• Scientific toxicology assessments
• Ingredient risk assessments
• Exposure modeling
• Dermatological safety evaluations
• Microbiological stability data

While animal testing is not mandated, all safety evidence must be scientifically valid and well-documented.

Cosmetic GMP Compliance & Quality Systems

MoCRA directs the FDA to establish mandatory Good Manufacturing Practice (GMP) regulations for cosmetics. Industry best practices include:

• Documented SOPs (Standard Operating Procedures)
• Raw material qualification
• Batch traceability
• Stability testing programs
• Contamination control measures
• Complaint handling procedures

Early adoption of cosmetic GMP frameworks reduces regulatory risk.

MOCRA Compliance Checklist

Latest Regulatory Trends (2024–2026 Updates)

To maximize compliance readiness, cosmetic companies must monitor:

• FDA draft guidance on cosmetic GMP rules
• Increased scrutiny of fragrance allergens
• PFAS ingredient regulatory review
• Microbiome-based cosmetic claims evaluation
• Sustainability and clean beauty labeling oversight
• Enhanced transparency requirements for imported cosmetics

Trending regulatory keywords include:

• Clean beauty compliance
• Cosmetic ingredient transparency
• FDA cosmetic facility registration portal
• Cosmetic labeling modernization
• INCI ingredient disclosure compliance
• Cosmetic recall management strategy

How Maven Regulatory Solutions Supports MOCRA Compliance

Navigating MOCRA requirements requires structured regulatory planning, scientific validation, and operational alignment. Maven Regulatory Solutions provides comprehensive regulatory services, including:

1. MOCRA Registration & Product Listing Support

• FDA cosmetic facility registration submission
• Biennial renewal management
• Cosmetic product listing preparation
• Regulatory portal documentation support

2. Safety Substantiation & Toxicology Assessment

• Cosmetic ingredient toxicological risk assessments
• Exposure and margin-of-safety calculations
• Preservative efficacy data review
• Dermatological safety evaluation support
• Safety dossier preparation

3. Adverse Event Management Systems

• Development of complaint reporting workflows
• 15-day FDA serious adverse event submission support
• Complaint handling SOP creation
• Record retention strategy implementation

4. Cosmetic GMP Implementation

• Gap analysis of FDA GMP expectations
• SOP development
• Quality management system integration
• Audit preparedness training

5. Regulatory Intelligence & Ongoing Monitoring

• Real-time regulatory updates
• FDA guidance interpretation
• Label compliance review
• Claims substantiation analysis

Maven ensures that cosmetic companies not only meet regulatory obligations but also build long-term compliance resilience.

Strategic Benefits of Early MOCRA Compliance

Proactive compliance delivers measurable advantages:

• Reduced enforcement risk
• Enhanced consumer trust
• Stronger retailer partnerships
• Streamlined product launches
• Improved inspection readiness
• Increased investor confidence

MOCRA compliance is now a competitive differentiator in the U.S. cosmetic marketplace.

Frequently Asked Questions (FAQ)

1. Is MOCRA registration mandatory for all cosmetic manufacturers?

Yes. Facilities manufacturing or processing cosmetics for U.S. distribution must register with the FDA.

2. What is the deadline for adverse event reporting?

Serious adverse events must be reported within 15 business days.

3. Does MOCRA require animal testing?

No. Animal testing is not mandatory, but scientifically valid safety substantiation is required.

4. Do imported cosmetics require product listing?

Yes. All cosmetics marketed in the U.S., including imports, must be listed.

5. What happens if a company fails to comply with MOCRA?

The FDA may issue warning letters, mandate recalls, suspend facility registration, or initiate enforcement actions.